BLOOD CANCER

Clinical trials for BLOOD CANCER explained in plain language.

Never miss a new study

Get alerted when new BLOOD CANCER trials appear

Sign up with your email to follow new studies for BLOOD CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 7 Not yet finished but already full! 1 Completed 2

New hope for transplant patients with stubborn blood cell shortages

Disease control Ongoing

This study tests a drug called isatuximab for people whose blood cell counts stay low after a stem cell transplant. It includes 12 adults whose cancer is in remission but who have not responded to other treatments. The goal is to see if isatuximab can help restore healthy blood c…

Matched conditions: BLOOD CANCER

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated May 17, 2026 02:07 UTC

BLOOD CANCER

Get alerted when new BLOOD CANCER trials appear

New hope for transplant patients with stubborn blood cell shortages